Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »The Immune Target Moved, but the Diabetes Didn’t: What a Failed Type 1 Trial Can Teach Us
Why Scientists Are Taking Another Look at the BCG Vaccine for Type 1 Diabetes
For more than 100 years, the Bacillus Calmette-Guérin (BCG) vaccine has been used worldwide to help prevent tuberculosis. However, researchers are now exploring another possible role for this familiar vaccine. Recent studies suggest that the BCG vaccine may play a role in treating type 1 diabetes by modifying the immune …
Read More »